Get the Stockscreener App
2.01
1.95%
-0.04
Bioline Rx Ltd Adr Stock (BLRX) Forecast
The Bioline Rx Ltd Adr (BLRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.8841, representing a -6.26% decrease from the current price of $2.01. The highest analyst price target is $2.1233, and the lowest is $1.645.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BLRX Price Target
Average 1.192
(-40.70% Downside)
Is Bioline Rx Ltd Adr (BLRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 24.99 | Buy |
| STOCH(9,6) | 17.16 | Buy |
| STOCHRSI(14) | 5.6818 | Buy |
| MACD(12,26) | -0.1395 | Sell |
| ADX(14) | 16.34 | Neutral |
| William %R | -88.18 | Buy |
| CCI(14) | -65.54 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.1718
Sell
|
2.1621
Sell
|
| MA20 |
2.3084
Sell
|
2.2744
Sell
|
| MA50 |
2.5352
Sell
|
2.4826
Sell
|
| MA100 |
2.816
Sell
|
2.6527
Sell
|
| MA200 |
2.7816
Sell
|
2.9128
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, BLRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on BLRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 24.99 indicates that BLRX is oversold. This indicates that BLRX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 17.16 indicates that BLRX is oversold. This indicates that BLRX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.6818 indicates that BLRX is oversold. This suggests that BLRX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.34 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -65.54 indicates that BLRX is still oversold but not to an extreme extent.
Long-term BLRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bioline Rx Ltd Adr financial reports and earnings history, Bioline Rx Ltd Adr (BLRX) stock could reach $0.1056 by 2030, $0.5692 by 2040 and $2.8034 by 2050. See the projected annual prices until 2050 of the Bioline Rx Ltd Adr stock below:
- Bioline Rx Ltd Adr (BLRX) is expected to reach an average price of $0.3632 in 2035, with a high prediction of $0.3032 and a low estimate of $0.1396. This indicates an $-81.93% rise from the last recorded price of $2.01.
- Bioline Rx Ltd Adr (BLRX) stock is projected to chart a bullish course in 2040, with an average price target of $0.6343, representing an $-68.44% surge from its current level. The forecast ranges from a conservative $0.6667 to a sky-high $0.5692.
- Our analysts predict Bioline Rx Ltd Adr (BLRX) to jump 23.78% by 2045, soaring from $2.4605 to an average price of $2.488, potentially reaching $2.4348. While $2.4605 is the low estimate, the potential upside is significant.
- Bioline Rx Ltd Adr (BLRX) stock is expected to climb by 2050, reaching an average of $2.4752, a $23.14% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.8034 and $2.8576, respectively, highlighting the market's uncertainty.
Bioline Rx Ltd Adr Stock (BLRX) Year by Year Forecast
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2026
The predicted value for Bioline Rx Ltd Adr (BLRX) in 2026 is set at an average of $2.5833. Estimates vary from a peak of $3.95 to a trough of $1.2166, indicating an +28.52% surge from the present price of $2.01.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1.795 | $1.645 | $2.1233 | -10.70% |
| December, 2026 | $1.3583 | $1.2166 | $2.1866 | -32.42% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bioline Rx Ltd Adr (BLRX) is $0.7246, with a high forecast of $1.4291 and a low forecast of $0.02. This indicates an -63.95% decrease from the last price of $2.01.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0016 | $0.9517 | $1.4291 | -50.17% |
| February, 2027 | $0.8849 | $0.8424 | $1.1341 | -55.98% |
| March, 2027 | $0.759 | $0.5166 | $1.0157 | -62.24% |
| April, 2027 | $1.0023 | $0.5899 | $1.0123 | -50.13% |
| May, 2027 | $0.4565 | $0.3857 | $1.0132 | -77.29% |
| June, 2027 | $0.7498 | $0.1973 | $0.819 | -62.70% |
| July, 2027 | $0.5431 | $0.4523 | $0.7706 | -72.98% |
| August, 2027 | $0.5072 | $0.3939 | $0.6664 | -74.76% |
| September, 2027 | $0.8706 | $0.4781 | $1.1796 | -56.69% |
| October, 2027 | $1.0239 | $0.6714 | $1.0239 | -49.06% |
| November, 2027 | $0.048 | $0.02 | $0.9947 | -97.61% |
| December, 2027 | $0.0714 | $0.0303 | $0.1387 | -96.45% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2028
In 2028, Bioline Rx Ltd Adr (BLRX) is projected to reach an average price of $0.9019, with a high projection of $1.7827 and a low estimate of $0.0212. This indicates an -55.13% fall from the last price of $2.01.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.069 | $0.1044 | $0.0921 | -96.56% |
| February, 2028 | $0.1912 | $0.13 | $0.1812 | -90.49% |
| March, 2028 | $0.1384 | $0.1088 | $0.0779 | -93.11% |
| April, 2028 | $0.1646 | $0.1763 | $0.1546 | -91.81% |
| May, 2028 | $0.1582 | $0.2055 | $0.173 | -92.13% |
| June, 2028 | $0.3328 | $0.0212 | $0.4628 | -83.44% |
| July, 2028 | $0.697 | $0.228 | $0.9661 | -65.32% |
| August, 2028 | $0.8262 | $0.6278 | $0.9243 | -58.90% |
| September, 2028 | $0.8986 | $0.7628 | $1.061 | -55.29% |
| October, 2028 | $0.8177 | $0.5061 | $1.0044 | -59.32% |
| November, 2028 | $1.001 | $0.4502 | $1.071 | -50.20% |
| December, 2028 | $1.3244 | $0.9035 | $1.7827 | -34.11% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2029
The 2029 price forecast for Bioline Rx Ltd Adr Stock (BLRX) is $0.7006 on average, with a high prediction of $1.3752 and a low estimate of $0.0259. This represents an -65.15% decrease from the previous price of $2.01.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.5685 | $0.5085 | $1.3752 | -71.72% |
| February, 2029 | $0.9518 | $0.5193 | $1.1918 | -52.65% |
| March, 2029 | $1.0451 | $0.6335 | $1.1551 | -48.00% |
| April, 2029 | $0.6792 | $0.6492 | $1.0809 | -66.21% |
| May, 2029 | $0.4126 | $0.3209 | $0.6981 | -79.47% |
| June, 2029 | $0.6059 | $0.2834 | $0.6359 | -69.86% |
| July, 2029 | $0.40 | $0.28 | $0.7167 | -80.10% |
| August, 2029 | $0.1051 | $0.0683 | $0.3808 | -94.77% |
| September, 2029 | $0.0734 | $0.0712 | $0.0465 | -96.35% |
| October, 2029 | $0.1192 | $0.0559 | $0.1383 | -94.07% |
| November, 2029 | $0.1241 | $0.0259 | $0.1833 | -93.83% |
| December, 2029 | $0.0367 | $0.0464 | $0.1849 | -98.17% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2030
Bioline Rx Ltd Adr Stock (BLRX) is expected to reach an average price of $3.5531 in 2030, with a high forecast of $7.1062 and a low forecast of $0.000043. This signifies an +76.77% surge from the last price of $2.01.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.0774 | $0.000043 | $0.1056 | -96.15% |
| February, 2030 | $0.2352 | $0.0768 | $0.0822 | -88.30% |
| March, 2030 | $0.2817 | $0.2633 | $0.2419 | -85.99% |
| April, 2030 | $0.3907 | $0.2599 | $0.3877 | -80.56% |
| May, 2030 | $0.4628 | $0.4562 | $0.4602 | -76.97% |
| June, 2030 | $0.5796 | $0.4626 | $0.5311 | -71.16% |
| July, 2030 | $2.913 | $0.5794 | $3.7606 | +44.93% |
| August, 2030 | $2.9064 | $2.3355 | $3.1239 | +44.59% |
| September, 2030 | $2.2105 | $1.6298 | $2.8772 | +9.97% |
| October, 2030 | $2.5038 | $2.1313 | $2.823 | +24.57% |
| November, 2030 | $5.0771 | $2.3446 | $7.1062 | +152.59% |
| December, 2030 | $3.8313 | $3.1296 | $5.9279 | +90.61% |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):